Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
Clinical trial NCT02343406 · COMPLETED
Trial details
- NCT number
- NCT02343406
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-17
- Primary completion
- 2019-06-24
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.